Saroja Pharma Industries India Limited (NSE:SAROJA)

India · Delayed Price · Currency is INR

40.00

0.00 (0.00%)

Nov 8, 2026, 2:47 PM IST

NSE:SAROJA Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	701.29	701.29	537.27	406.69	501.93	556.33
Revenue Growth	-4.41%	30.53%	32.11%	-18.97%	-9.78%	51.75%
Gross Profit	63.03	63.03	51.46	50.27	48.97	52.8
Operating Income	37.11	37.11	27.5	26.04	27.14	22.14
Net Income	16.14	16.14	10.34	8.78	10.61	11.4
Earnings Per Share	4.02	4.02	2.57	2.49	3.61	3.96
EPS Growth	26.90%	56.24%	3.29%	-31.08%	-8.84%	47.28%

Revenue by Geography

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	667.25	667.25	491.69	336.21	450.03	434.58
Asia Pacific	31.41	31.41	45.58	60.11	46.63	-
Europe	2.63	2.63	-	9.35	0.46	-
Total	701.29	701.29	537.27	406.69	497.12	556.33

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	3.39	3.39	3.32	3.22	3.64	2.65
Total Debt	144.15	144.15	94.56	57.35	101.89	61.39
Net Cash (Debt)	-140.76	-140.76	-91.24	-54.13	-98.25	-58.74
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-35.01	-35.01	-22.69	-15.33	-33.44	-20.43

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	74.41	74.41	11.48	10.25	21.93	-36.74
Capital Expenditures	-117.24	-117.24	-25.95	-47.29	-37.26	-3.02
Free Cash Flow	-42.84	-42.84	-14.46	-37.04	-15.34	-39.76
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	8.99%	8.99%	9.58%	12.36%	9.76%	9.49%
Operating Margin	5.29%	5.29%	5.12%	6.40%	5.41%	3.98%
Pretax Margin	3.18%	3.18%	2.70%	2.97%	2.97%	2.84%
Profit Margin	2.30%	2.30%	1.93%	2.16%	2.11%	2.05%
FCF Margin	-6.11%	-6.11%	-2.69%	-9.11%	-3.06%	-7.15%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 10, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	9.96	6.97	14.68	16.07	-	-
PS Ratio	0.23	0.16	0.28	0.35	-	-